Global Biosimilars of Monoclonal Antibody Market Research Report 2017

July 2017 | 112 pages | ID: G3571CD9DCFEN
QYResearch

Abstracts

In this report, the global Biosimilars of Monoclonal Antibody market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biosimilars of Monoclonal Antibody in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Biosimilars of Monoclonal Antibody market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Pfizer
• Roche
• Eli Lilly
• Bayer
• Amgen
• Sanofi-Aventis
• Johnson & Johnson
• Novo Nordisk
• Merck
• GSK
• BMS

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Type I
• Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Biosimilars of Monoclonal Antibody for each application, including

• Application 1
• Application 2

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Biosimilars of Monoclonal Antibody Market Research Report 2017

1 BIOSIMILARS OF MONOCLONAL ANTIBODY MARKET OVERVIEW

1.1 Product Overview and Scope of Biosimilars of Monoclonal Antibody
1.2 Biosimilars of Monoclonal Antibody Segment by Type (Product Category)
  1.2.1 Global Biosimilars of Monoclonal Antibody Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
  1.2.2 Global Biosimilars of Monoclonal Antibody Production Market Share by Type (Product Category) in 2016
  1.2.3 Type I
  1.2.4 Type II
1.3 Global Biosimilars of Monoclonal Antibody Segment by Application
  1.3.1 Biosimilars of Monoclonal Antibody Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Application
  1.3.3 Application
1.4 Global Biosimilars of Monoclonal Antibody Market by Region (2012-2022)
  1.4.1 Global Biosimilars of Monoclonal Antibody Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Biosimilars of Monoclonal Antibody (2012-2022)
  1.5.1 Global Biosimilars of Monoclonal Antibody Revenue Status and Outlook (2012-2022)
  1.5.2 Global Biosimilars of Monoclonal Antibody Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL BIOSIMILARS OF MONOCLONAL ANTIBODY MARKET COMPETITION BY MANUFACTURERS

2.1 Global Biosimilars of Monoclonal Antibody Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Biosimilars of Monoclonal Antibody Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Biosimilars of Monoclonal Antibody Production and Share by Manufacturers (2012-2017)
2.2 Global Biosimilars of Monoclonal Antibody Revenue and Share by Manufacturers (2012-2017)
2.3 Global Biosimilars of Monoclonal Antibody Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Biosimilars of Monoclonal Antibody Manufacturing Base Distribution, Sales Area and Product Type
2.5 Biosimilars of Monoclonal Antibody Market Competitive Situation and Trends
  2.5.1 Biosimilars of Monoclonal Antibody Market Concentration Rate
  2.5.2 Biosimilars of Monoclonal Antibody Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL BIOSIMILARS OF MONOCLONAL ANTIBODY CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Biosimilars of Monoclonal Antibody Capacity and Market Share by Region (2012-2017)
3.2 Global Biosimilars of Monoclonal Antibody Production and Market Share by Region (2012-2017)
3.3 Global Biosimilars of Monoclonal Antibody Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL BIOSIMILARS OF MONOCLONAL ANTIBODY SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Biosimilars of Monoclonal Antibody Consumption by Region (2012-2017)
4.2 North America Biosimilars of Monoclonal Antibody Production, Consumption, Export, Import (2012-2017)
4.3 Europe Biosimilars of Monoclonal Antibody Production, Consumption, Export, Import (2012-2017)
4.4 China Biosimilars of Monoclonal Antibody Production, Consumption, Export, Import (2012-2017)
4.5 Japan Biosimilars of Monoclonal Antibody Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Biosimilars of Monoclonal Antibody Production, Consumption, Export, Import (2012-2017)
4.7 India Biosimilars of Monoclonal Antibody Production, Consumption, Export, Import (2012-2017)

5 GLOBAL BIOSIMILARS OF MONOCLONAL ANTIBODY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Biosimilars of Monoclonal Antibody Production and Market Share by Type (2012-2017)
5.2 Global Biosimilars of Monoclonal Antibody Revenue and Market Share by Type (2012-2017)
5.3 Global Biosimilars of Monoclonal Antibody Price by Type (2012-2017)
5.4 Global Biosimilars of Monoclonal Antibody Production Growth by Type (2012-2017)

6 GLOBAL BIOSIMILARS OF MONOCLONAL ANTIBODY MARKET ANALYSIS BY APPLICATION

6.1 Global Biosimilars of Monoclonal Antibody Consumption and Market Share by Application (2012-2017)
6.2 Global Biosimilars of Monoclonal Antibody Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL BIOSIMILARS OF MONOCLONAL ANTIBODY MANUFACTURERS PROFILES/ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Pfizer Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Roche
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Roche Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Eli Lilly
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Eli Lilly Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Bayer
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Bayer Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Amgen
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Amgen Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Sanofi-Aventis
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Sanofi-Aventis Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Johnson & Johnson
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Johnson & Johnson Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Novo Nordisk
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Novo Nordisk Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Merck
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Merck Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 GSK
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 GSK Biosimilars of Monoclonal Antibody Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 BMS

8 BIOSIMILARS OF MONOCLONAL ANTIBODY MANUFACTURING COST ANALYSIS

8.1 Biosimilars of Monoclonal Antibody Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Biosimilars of Monoclonal Antibody

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Biosimilars of Monoclonal Antibody Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Biosimilars of Monoclonal Antibody Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL BIOSIMILARS OF MONOCLONAL ANTIBODY MARKET FORECAST (2017-2022)

12.1 Global Biosimilars of Monoclonal Antibody Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Biosimilars of Monoclonal Antibody Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Biosimilars of Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Biosimilars of Monoclonal Antibody Price and Trend Forecast (2017-2022)
12.2 Global Biosimilars of Monoclonal Antibody Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Biosimilars of Monoclonal Antibody Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Biosimilars of Monoclonal Antibody Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Biosimilars of Monoclonal Antibody Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Biosimilars of Monoclonal Antibody Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Biosimilars of Monoclonal Antibody Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Biosimilars of Monoclonal Antibody Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Biosimilars of Monoclonal Antibody Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Biosimilars of Monoclonal Antibody Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biosimilars of Monoclonal Antibody
Figure Global Biosimilars of Monoclonal Antibody Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Biosimilars of Monoclonal Antibody Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Global Biosimilars of Monoclonal Antibody Consumption (K Units) by Applications (2012-2022)
Figure Global Biosimilars of Monoclonal Antibody Consumption Market Share by Applications in 2016
Figure Application 1 Examples
Table Key Downstream Customer in Application
Figure Application 2 Examples
Table Key Downstream Customer in Application
Figure Global Biosimilars of Monoclonal Antibody Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Biosimilars of Monoclonal Antibody Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Biosimilars of Monoclonal Antibody Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Biosimilars of Monoclonal Antibody Major Players Product Capacity (K Units) (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Capacity (K Units) of Key Manufacturers in 2016
Figure Global Biosimilars of Monoclonal Antibody Capacity (K Units) of Key Manufacturers in 2017
Figure Global Biosimilars of Monoclonal Antibody Major Players Product Production (K Units) (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Production (K Units) of Key Manufacturers (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Production Share by Manufacturers (2012-2017)
Figure 2016 Biosimilars of Monoclonal Antibody Production Share by Manufacturers
Figure 2017 Biosimilars of Monoclonal Antibody Production Share by Manufacturers
Figure Global Biosimilars of Monoclonal Antibody Major Players Product Revenue (Million USD) (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Biosimilars of Monoclonal Antibody Revenue Share by Manufacturers
Table 2017 Global Biosimilars of Monoclonal Antibody Revenue Share by Manufacturers
Table Global Market Biosimilars of Monoclonal Antibody Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Biosimilars of Monoclonal Antibody Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Biosimilars of Monoclonal Antibody Manufacturing Base Distribution and Sales Area
Table Manufacturers Biosimilars of Monoclonal Antibody Product Category
Figure Biosimilars of Monoclonal Antibody Market Share of Top 3 Manufacturers
Figure Biosimilars of Monoclonal Antibody Market Share of Top 5 Manufacturers
Table Global Biosimilars of Monoclonal Antibody Capacity (K Units) by Region (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Capacity Market Share by Region (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Capacity Market Share by Region (2012-2017)
Figure 2016 Global Biosimilars of Monoclonal Antibody Capacity Market Share by Region
Table Global Biosimilars of Monoclonal Antibody Production by Region (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Production (K Units) by Region (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Production Market Share by Region (2012-2017)
Figure 2016 Global Biosimilars of Monoclonal Antibody Production Market Share by Region
Table Global Biosimilars of Monoclonal Antibody Revenue (Million USD) by Region (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Revenue Market Share by Region (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Revenue Market Share by Region (2012-2017)
Table 2016 Global Biosimilars of Monoclonal Antibody Revenue Market Share by Region
Figure Global Biosimilars of Monoclonal Antibody Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Consumption (K Units) Market by Region (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Consumption Market Share by Region (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Consumption Market Share by Region (2012-2017)
Figure 2016 Global Biosimilars of Monoclonal Antibody Consumption (K Units) Market Share by Region
Table North America Biosimilars of Monoclonal Antibody Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Biosimilars of Monoclonal Antibody Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Biosimilars of Monoclonal Antibody Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Biosimilars of Monoclonal Antibody Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Biosimilars of Monoclonal Antibody Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Biosimilars of Monoclonal Antibody Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Production (K Units) by Type (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Production Share by Type (2012-2017)
Figure Production Market Share of Biosimilars of Monoclonal Antibody by Type (2012-2017)
Figure 2016 Production Market Share of Biosimilars of Monoclonal Antibody by Type
Table Global Biosimilars of Monoclonal Antibody Revenue (Million USD) by Type (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Biosimilars of Monoclonal Antibody by Type (2012-2017)
Figure 2016 Revenue Market Share of Biosimilars of Monoclonal Antibody by Type
Table Global Biosimilars of Monoclonal Antibody Price (USD/Unit) by Type (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Production Growth by Type (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Consumption (K Units) by Application (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Consumption Market Share by Application (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Consumption Market Share by Applications (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Consumption Market Share by Application in 2016
Table Global Biosimilars of Monoclonal Antibody Consumption Growth Rate by Application (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Consumption Growth Rate by Application (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Biosimilars of Monoclonal Antibody Production Growth Rate (2012-2017)
Figure Pfizer Biosimilars of Monoclonal Antibody Production Market Share (2012-2017)
Figure Pfizer Biosimilars of Monoclonal Antibody Revenue Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Biosimilars of Monoclonal Antibody Production Growth Rate (2012-2017)
Figure Roche Biosimilars of Monoclonal Antibody Production Market Share (2012-2017)
Figure Roche Biosimilars of Monoclonal Antibody Revenue Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Biosimilars of Monoclonal Antibody Production Growth Rate (2012-2017)
Figure Eli Lilly Biosimilars of Monoclonal Antibody Production Market Share (2012-2017)
Figure Eli Lilly Biosimilars of Monoclonal Antibody Revenue Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Biosimilars of Monoclonal Antibody Production Growth Rate (2012-2017)
Figure Bayer Biosimilars of Monoclonal Antibody Production Market Share (2012-2017)
Figure Bayer Biosimilars of Monoclonal Antibody Revenue Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Biosimilars of Monoclonal Antibody Production Growth Rate (2012-2017)
Figure Amgen Biosimilars of Monoclonal Antibody Production Market Share (2012-2017)
Figure Amgen Biosimilars of Monoclonal Antibody Revenue Market Share (2012-2017)
Table Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi-Aventis Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Biosimilars of Monoclonal Antibody Production Growth Rate (2012-2017)
Figure Sanofi-Aventis Biosimilars of Monoclonal Antibody Production Market Share (2012-2017)
Figure Sanofi-Aventis Biosimilars of Monoclonal Antibody Revenue Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biosimilars of Monoclonal Antibody Production Growth Rate (2012-2017)
Figure Johnson & Johnson Biosimilars of Monoclonal Antibody Production Market Share (2012-2017)
Figure Johnson & Johnson Biosimilars of Monoclonal Antibody Revenue Market Share (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Biosimilars of Monoclonal Antibody Production Growth Rate (2012-2017)
Figure Novo Nordisk Biosimilars of Monoclonal Antibody Production Market Share (2012-2017)
Figure Novo Nordisk Biosimilars of Monoclonal Antibody Revenue Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Biosimilars of Monoclonal Antibody Production Growth Rate (2012-2017)
Figure Merck Biosimilars of Monoclonal Antibody Production Market Share (2012-2017)
Figure Merck Biosimilars of Monoclonal Antibody Revenue Market Share (2012-2017)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Biosimilars of Monoclonal Antibody Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Biosimilars of Monoclonal Antibody Production Growth Rate (2012-2017)
Figure GSK Biosimilars of Monoclonal Antibody Production Market Share (2012-2017)
Figure GSK Biosimilars of Monoclonal Antibody Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilars of Monoclonal Antibody
Figure Manufacturing Process Analysis of Biosimilars of Monoclonal Antibody
Figure Biosimilars of Monoclonal Antibody Industrial Chain Analysis
Table Raw Materials Sources of Biosimilars of Monoclonal Antibody Major Manufacturers in 2016
Table Major Buyers of Biosimilars of Monoclonal Antibody
Table Distributors/Traders List
Figure Global Biosimilars of Monoclonal Antibody Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Price (Million USD) and Trend Forecast (2017-2022)
Table Global Biosimilars of Monoclonal Antibody Production (K Units) Forecast by Region (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Production Market Share Forecast by Region (2017-2022)
Table Global Biosimilars of Monoclonal Antibody Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Consumption Market Share Forecast by Region (2017-2022)
Figure North America Biosimilars of Monoclonal Antibody Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Biosimilars of Monoclonal Antibody Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Biosimilars of Monoclonal Antibody Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Biosimilars of Monoclonal Antibody Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Biosimilars of Monoclonal Antibody Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Biosimilars of Monoclonal Antibody Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Biosimilars of Monoclonal Antibody Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Biosimilars of Monoclonal Antibody Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Biosimilars of Monoclonal Antibody Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Biosimilars of Monoclonal Antibody Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Biosimilars of Monoclonal Antibody Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Biosimilars of Monoclonal Antibody Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Biosimilars of Monoclonal Antibody Production (K Units) Forecast by Type (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Production (K Units) Forecast by Type (2017-2022)
Table Global Biosimilars of Monoclonal Antibody Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Revenue Market Share Forecast by Type (2017-2022)
Table Global Biosimilars of Monoclonal Antibody Price Forecast by Type (2017-2022)
Table Global Biosimilars of Monoclonal Antibody Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source